The role of laboratory medicine in healthcare: Quality requirements of immunoassays, standardisation and data management in prospective medicine

EPMA Journal

Volumn 1, Issue 4, 2010, Pages 619-626

  Waerner, Thomas ^a   Thurnher, Dietmar ^b   Krapfenbauer, Kurt ^a  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ELISA; Laboratory workflow; Multiplex assay; Quality guidelines; Quality requirements; Validation

Indexed keywords

BIOLOGICAL MARKER;

ANALYTICAL ERROR; ANALYTICAL PARAMETERS; CLINICAL LABORATORY; DIFFERENTIAL DISPLAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; IMMUNOASSAY; INFORMATION PROCESSING; MEDICAL RESEARCH; MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; STANDARDIZATION; VALIDATION PROCESS; WORKFLOW;

EID: 79953065807     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0053-y     Document Type: Review

References (12)

1. Hunt KJ, Lehman DM, Arya R, Fowler S, Leach RJ, Göring HH, et al. Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study 2005. Diabetes. 2005; 54(9): 2655-62.
2. Molloy MP, Brzezinski EE, Hang J, McDowell MT, VanBogelen RA. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics. 2003; 3(10): 1912-9.
3. Karp JM, Friis EA, Dee KC, Winet H. Opinions and trends in biomaterials education: report of a 2003 Society for Biomaterials survey. J Biomed Mater Res A. 2004; 70(1): 1-9.
4. ICH Guidelines: Q2(R2), Validation of analytical procedures: text and methodology. 2005; Q6B, Specifications: test procedures and acceptance criteria for biotechnological/biological products. 1999.
5. United States Pharmacopeia <1032> Design and development of biological assays; draft version 2010, public in 2011.
6. United States Pharmacopeia <1034> Analysis of biological assays; draft version 2010, public in 2011.
7. Durr PA, Eastland S. Use of web-enabled databases for complex animal health investigations. Rev Sci Tech. 2004; 23(3): 873-84.
8. Lui H, Qiu T. Knowledge discovery in database and its application in clinical diagnosis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004; 21(4): 677-80.
9. Orchard S, Hermjakob H, Taylor CF, Potthast F, Jones P, Zhu W, et al. Further steps in standardisation. Report of the second annual Proteomics Standards Initiative Spring Workshop (Siena, Italy 17-20th April 2005). Proteomics. 2005; 5(14): 3552-5.
10. Challapalli KK, Zabel C, Schuchhardt J, Kaindl AM, Klose J, Herzel H. High reproducibility of large-gel two-dimensional electrophoresis. Electrophoresis. 2004; 25(17): 3040-7.
11. Findlay JW, Smith WC, Lee JW, Nordblom GD, Das I, DeSilva BS, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000; 21(6): 1249-73.
12. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000; 11(6 Pt 1): 805-21.